Periodic publication of aggregate safety reports & compiled drug data gives Regulatory Authorities a thorough insight of a drug’s safety profile.
Periodic publication of aggregate safety reports & compiled drug data gives Regulatory Authorities a thorough insight of a drug’s safety profile. The MAH regularly monitors and closely evaluates the pharmaceutical product Risk-safety balance and takes necessary action whenever new risks or changes to existing risk are detected.
Periodic publication of aggregate safety reports & compiled drug data gives Regulatory Authorities a thorough insight of a drug’s safety profile. The MAH regularly monitors and closely evaluates the pharmaceutical product Risk-safety balance and takes necessary action whenever new risks or changes to existing risk are detected.
PVG Pharmasciences has extensive experience in delivering aggregate reports, including Periodic Adverse Drug Experience Reports (PADERs), DSURs, IND Safety Reports, and PSURs / Periodic Benefit Risk Evaluation Reports (PBRERs). We assist our clients in actively managing their reporting calendars, collaborating in data collection as necessary, and producing aggregate reports that are suitable for regulatory submission.
PVG Pharmasciences is looking for variety of roles, and talented individuals to join our team
Drop your CV at info@pvgpharmasciences.com
